Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Urine Cell-Free MicroRNAs in Localized Prostate Cancer Patients.
Koh Y, Bustos MA, Moon J, Gross R, Ramos RI, Ryu S, Choe J, Lin SY, Allen WM, Krasne DL, Wilson TG, Hoon DSB. Koh Y, et al. Cancers (Basel). 2022 May 12;14(10):2388. doi: 10.3390/cancers14102388. Cancers (Basel). 2022. PMID: 35625992 Free PMC article.
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer.
Hayashi Y, Fujita K, Matsuzaki K, Eich ML, Tomiyama E, Matsushita M, Koh Y, Nakano K, Wang C, Ishizuya Y, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Imamura R, Netto GJ, Nonomura N. Hayashi Y, et al. Among authors: koh y. Front Oncol. 2020 May 19;10:755. doi: 10.3389/fonc.2020.00755. eCollection 2020. Front Oncol. 2020. PMID: 32509577 Free PMC article.
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.
Hayashi Y, Fujita K, Matsuzaki K, Matsushita M, Kawamura N, Koh Y, Nakano K, Wang C, Ishizuya Y, Yamamoto Y, Jingushi K, Kato T, Kawashima A, Ujike T, Nagahara A, Uemura M, Imamura R, Takao T, Takada S, Netto GJ, Nonomura N. Hayashi Y, et al. Among authors: koh y. Cancer Sci. 2019 May;110(5):1771-1779. doi: 10.1111/cas.14000. Epub 2019 Apr 7. Cancer Sci. 2019. PMID: 30887605 Free PMC article.
Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma.
Yamamoto Y, Uemura M, Fujita M, Maejima K, Koh Y, Matsushita M, Nakano K, Hayashi Y, Wang C, Ishizuya Y, Kinouchi T, Hayashi T, Matsuzaki K, Jingushi K, Kato T, Kawashima A, Ujike T, Nagahara A, Fujita K, Imamura R, Nakagawa H, Nonomura N. Yamamoto Y, et al. Among authors: koh y. Cancer Sci. 2019 Feb;110(2):617-628. doi: 10.1111/cas.13906. Epub 2019 Jan 25. Cancer Sci. 2019. PMID: 30536551 Free PMC article.
Fragmentation of cell-free DNA is induced by upper-tract urothelial carcinoma-associated systemic inflammation.
Nakano K, Yamamoto Y, Yamamichi G, Yumiba S, Tomiyama E, Matsushita M, Koh Y, Hayashi Y, Wang C, Ishizuya Y, Kato T, Hatano K, Kawashima A, Ujike T, Fujita K, Nonomura N, Uemura M. Nakano K, et al. Among authors: koh y. Cancer Sci. 2021 Jan;112(1):168-177. doi: 10.1111/cas.14679. Epub 2020 Nov 12. Cancer Sci. 2021. PMID: 33027843 Free PMC article.
Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma.
Kato T, Kiyotani K, Tomiyama E, Koh Y, Matsushita M, Hayashi Y, Nakano K, Ishizuya Y, Wang C, Hatano K, Kawashima A, Ujike T, Fujita K, Nonomura N, Uemura M. Kato T, et al. Among authors: koh y. Oncoimmunology. 2021 Jan 19;10(1):1862948. doi: 10.1080/2162402X.2020.1862948. Oncoimmunology. 2021. PMID: 33537170 Free PMC article.
Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinoma.
Koh Y, Nakano K, Katayama K, Yamamichi G, Yumiba S, Tomiyama E, Matsushita M, Hayashi Y, Yamamoto Y, Kato T, Hatano K, Kawashima A, Ujike T, Imamura R, Yamaguchi R, Imoto S, Shiotsu Y, Nonomura N, Uemura M. Koh Y, et al. Int J Urol. 2022 May;29(5):462-469. doi: 10.1111/iju.14816. Epub 2022 Feb 19. Int J Urol. 2022. PMID: 35184335 Free PMC article.
TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer.
Hayashi Y, Fujita K, Nojima S, Tomiyama E, Matsushita M, Koh Y, Nakano K, Wang C, Ishizuya Y, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Imamura R, Morii E, Nonomura N. Hayashi Y, et al. Among authors: koh y. Mol Oncol. 2020 Oct;14(10):2375-2383. doi: 10.1002/1878-0261.12746. Epub 2020 Jun 27. Mol Oncol. 2020. PMID: 32533903 Free PMC article.
Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma.
Nakano K, Koh Y, Yamamichi G, Yumiba S, Tomiyama E, Matsushita M, Hayashi Y, Wang C, Ishizuya Y, Yamamoto Y, Kato T, Hatano K, Kawashima A, Ujike T, Fujita K, Kiyotani K, Katayama K, Yamaguchi R, Imoto S, Imamura R, Nonomura N, Uemura M. Nakano K, et al. Among authors: koh y. Cancer Sci. 2022 May;113(5):1830-1842. doi: 10.1111/cas.15334. Epub 2022 Mar 24. Cancer Sci. 2022. PMID: 35293110 Free PMC article.
3,119 results